Stay updated with breaking news from Clive Ballard. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Quality of life for people with dementia living in residential and nursing home care substantially improved after staff took part in a digital training programme that was specially adapted to Covid-19 restrictions.
New positive data for brexpiprazole, the first and only treatment approved to treat agitation associated with dementia due to Alzheimer disease.
People who have had concussions should be warned of the dangers of continuing high-risk sport or work, according to the researchers.
Researchers reported that a phase 3 study showed statistically significant improvement in patients with agitation related to Alzheimer's who took the atypical antipsychotic brexpiprazole.
University of Exeter and King's College London researchers found the use of antipsychotic drugs on dementia patients at care homes soared from 18 per cent in 2017 to 28 per cent this year.